An analysis conducted by Starr and associates showed that patients with high disease burden in the liver did not experience liver failure with PRRT.
Jason Starr, DO
Advertisement
Articles by Jason Starr, DO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
How Might CAR T Cells and Bispecifics Evolve in Multiple Myeloma Therapy?
2
FDA OKs Oral Decitabine/Cedazuridine Plus Venetoclax in Newly Diagnosed AML
3
FDA Approves Sonrotoclax in Relapsed/Refractory Mantle Cell Lymphoma
4
Zoldonrasib Shows Promising Activity in KRAS G12D+ NSCLC
5